Aculabs is a trusted leader in clinical diagnostic lab services for long-term care - delivering accuracy, reliability, and service with integrity.

The Accula™ SARS-CoV-2 Test* performed on the Accula Dock or the Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies for the …

While the workflow is simple, the Accula requires precise adherence to stated workflow for sample collection, handling, processing and storage to minimize the potential for errors and invalid and …

The AcculaTM SARS-CoV-2 Test performed on the Accula Dock or the SilarisTM Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies...

The Thermo Fisher Scientific Accula system is a rapid diagnostic point of care platform that provides simple, accurate sample-to-answer rapid PCR. Using a palm-sized Accula Dock in a CLIA waived …

The Accula SARS-CoV-2 Test is now authorized for clinician-guided patient self-collection and elution of the nasal swab sample - includes a Self-Collection Quick Reference Guide

The Accula System from Thermo Fisher Scientific the gold-standard rapid diagnostic platform that combines the accuracy of RT_PCR with the simplicity, convenience, and procedural familiarity of …

The Accula SARS-CoV-2 Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of …

The Accula SARS-CoV-2 Test combines RT-PCR accuracy with a simple workflow to provide fast and convenient rapid PCR-based test results. The test’s patented PCR technology enables rapid …

This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Accula SARS-CoV-2 Test. The Accula SARS-CoV-2 Test is authorized for use on using …